• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

染色体微阵列分析在胎儿宫内生长受限产前诊断中的应用。

Interest of chromosomal microarray analysis in the prenatal diagnosis of fetal intrauterine growth restriction.

机构信息

Centre Aliénor d'Aquitaine Maternity, CHU Bordeaux, Bordeaux, France.

Service de Génétique Médicale, CHU Bordeaux, Bordeaux, France.

出版信息

Prenat Diagn. 2018 Dec;38(13):1111-1119. doi: 10.1002/pd.5372. Epub 2018 Nov 22.

DOI:10.1002/pd.5372
PMID:30328630
Abstract

OBJECTIVE

The aim of this study is to evaluate the diagnostic utility of prenatal diagnosis using the chromosomal microarray analysis (CMA) for fetuses presenting with isolated or associated intrauterine growth restriction (IUGR).

METHOD

We retrospectively included all fetuses with IUGR referred for prenatal testing and studied by rapid fluorescence in situ hybridization (FISH), karyotype, and CMA.

RESULTS

Among the 162 IUGR fetuses (78 associated and 84 isolated IUGR) included, 15 had an abnormal FISH result: 10 associated and five isolated fetal IUGRs. Among the 143 fetuses studied by CMA, 10 (7%) presented pathogenic copy number variations (CNVs). All 10 were in the associated fetal IUGR group (10/65 or 15.4%; 95% confidence interval [CI]: 8.4%-26.2%) versus 0/78 in the isolated fetal IUGR group (95% CI: 0%-5.6%). Six fetuses (4.2%) carried variants of unknown significance (VOUS) (three associated and three isolated fetal IUGRs).

CONCLUSION

Our study highlights the added value of CMA in the case of associated fetal IUGR with an incremental yield of 6.1% (4/65) over karyotyping. No pathogenic CNVs were reported in the isolated fetal IUGR group. More studies must be conducted to determine when and whether CMA would be wisely indicated in this population.

摘要

目的

本研究旨在评估染色体微阵列分析(CMA)在诊断伴有或不伴有宫内生长受限(IUGR)的胎儿中的应用价值。

方法

我们回顾性纳入了所有因 IUGR 而接受产前检测的胎儿,并对其进行快速荧光原位杂交(FISH)、核型分析和 CMA 检查。

结果

在 162 例 IUGR 胎儿(78 例伴有 IUGR 和 84 例孤立性 IUGR)中,有 15 例 FISH 结果异常:10 例伴有 IUGR,5 例孤立性胎儿 IUGR。在 143 例接受 CMA 检查的胎儿中,有 10 例(7%)存在致病性拷贝数变异(CNVs)。所有 10 例均发生在伴有胎儿 IUGR 组(10/65 或 15.4%;95%置信区间[CI]:8.4%-26.2%),而在孤立性胎儿 IUGR 组中无 1 例(95%CI:0%-5.6%)。6 例(4.2%)携带意义不明的变异(VOUS)(3 例伴有胎儿 IUGR,3 例孤立性胎儿 IUGR)。

结论

本研究强调了 CMA 在伴有胎儿 IUGR 中的附加价值,相对于核型分析,其阳性率增加了 6.1%(4/65)。孤立性胎儿 IUGR 组未报告致病性 CNVs。需要进一步开展更多研究以确定何时以及是否明智地在该人群中开展 CMA。

相似文献

1
Interest of chromosomal microarray analysis in the prenatal diagnosis of fetal intrauterine growth restriction.染色体微阵列分析在胎儿宫内生长受限产前诊断中的应用。
Prenat Diagn. 2018 Dec;38(13):1111-1119. doi: 10.1002/pd.5372. Epub 2018 Nov 22.
2
Chromosomal Microarray Analysis in Fetuses with Growth Restriction and Normal Karyotype: A Systematic Review and Meta-Analysis.染色体微阵列分析在生长受限且核型正常的胎儿中的应用:一项系统评价和荟萃分析
Fetal Diagn Ther. 2018;44(1):1-9. doi: 10.1159/000479506. Epub 2017 Sep 9.
3
Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study.是否应提供产前染色体微阵列分析用于孤立性胎儿生长受限?一项法国多中心研究。
Am J Obstet Gynecol. 2021 Dec;225(6):676.e1-676.e15. doi: 10.1016/j.ajog.2021.05.035. Epub 2021 May 29.
4
Application of chromosomal microarray analysis in prenatal diagnosis of fetal growth restriction.染色体微阵列分析在胎儿生长受限产前诊断中的应用。
Prenat Diagn. 2016 Jul;36(7):686-92. doi: 10.1002/pd.4844. Epub 2016 Jun 21.
5
Utility of chromosomal microarray analysis for the exploration of isolated and severe fetal growth restriction diagnosed before 24 weeks' gestation.探讨在 24 周前诊断的孤立性和严重胎儿生长受限中应用染色体微阵列分析的效用。
Prenat Diagn. 2022 Sep;42(10):1281-1287. doi: 10.1002/pd.6149. Epub 2022 Apr 18.
6
Clinical utility of array comparative genomic hybridisation in prenatal setting.产前环境中阵列比较基因组杂交的临床应用。
BMC Med Genet. 2016 Nov 15;17(1):81. doi: 10.1186/s12881-016-0345-8.
7
[Clinical value of genome-wide high resolution chromosomal microarray analysis in etiological study of fetuses with congenital heart defects].[全基因组高分辨率染色体微阵列分析在先天性心脏病胎儿病因学研究中的临床价值]
Zhonghua Fu Chan Ke Za Zhi. 2014 Dec;49(12):893-8.
8
Prenatal diagnosis and molecular cytogenetic characterization of fetuses with central nervous system anomalies using chromosomal microarray analysis: a seven-year single-center retrospective study.利用染色体微阵列分析对中枢神经系统异常胎儿进行产前诊断及分子细胞遗传学特征分析:一项为期七年的单中心回顾性研究
Sci Rep. 2024 Jan 27;14(1):2271. doi: 10.1038/s41598-024-52831-9.
9
Performance of Chromosomal Microarray Analysis for Detection of Copy Number Variations in Fetal Echogenic Bowel.染色体微阵列分析在检测胎儿肠回声增强中拷贝数变异的性能
Risk Manag Healthc Policy. 2021 Apr 9;14:1431-1438. doi: 10.2147/RMHP.S299806. eCollection 2021.
10
Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis.颈部半透明厚度增加且核型正常的胎儿的基因组微阵列:一项系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2015 Dec;46(6):650-8. doi: 10.1002/uog.14880.

引用本文的文献

1
The Genetic and Clinical Outcomes in Fetuses With Isolated Fetal Growth Restriction: A Chinese Single-Center Retrospective Study.孤立性胎儿生长受限胎儿的遗传与临床结局:一项中国单中心回顾性研究
Front Genet. 2022 Apr 28;13:856522. doi: 10.3389/fgene.2022.856522. eCollection 2022.
2
Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges-Systematic Review of the Literature and Meta-Analysis.胎儿畸形、动态异常和软指标的分子检测方法:诊断率与挑战——文献系统综述与荟萃分析
Diagnostics (Basel). 2022 Feb 23;12(3):575. doi: 10.3390/diagnostics12030575.
3
FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.
国际妇产科联盟(FIGO)胎儿生长倡议:胎儿生长受限筛查、诊断及管理的最佳实践建议
Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1):3-57. doi: 10.1002/ijgo.13522.